Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
19,505
datasets available to search
ShareScore release 0.9.0
Dataset results
19,505 results for “advanced;”
Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers
ClinicalTrials.gov study NCT04010227. IPD Sharing: YES. Countries: 1. Publications: 2.
Advancing Symptom Alleviation With Palliative Treatment
ClinicalTrials.gov study NCT02713347. IPD Sharing: NO. Countries: 1. Publications: 23.
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03586973. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoi
ClinicalTrials.gov study NCT03945773. IPD Sharing: YES. Countries: 7. Publications: 1.
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients
ClinicalTrials.gov study NCT03623243. IPD Sharing: YES. Countries: 2. Publications: 1.
Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies
ClinicalTrials.gov study NCT03637764. IPD Sharing: YES. Countries: 8. Publications: 1.
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03783442. IPD Sharing: YES. Countries: 16. Publications: 2.
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma
ClinicalTrials.gov study NCT02967692. IPD Sharing: YES. Countries: 29. Publications: 3.
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies
ClinicalTrials.gov study NCT03370302. IPD Sharing: YES. Countries: 3. Publications: 1.
Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer
ClinicalTrials.gov study NCT00408434. IPD Sharing: YES. Countries: 1. Publications: 1.
Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04744831. IPD Sharing: YES. Countries: 10. Publications: 2.
Study of DS-8201a for Participants With Advanced Solid Malignant Tumors
ClinicalTrials.gov study NCT03383692. IPD Sharing: YES. Countries: 3. Publications: 1.
Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
ClinicalTrials.gov study NCT02460224. IPD Sharing: UNDECIDED. Countries: 12. Publications: 2.
A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-s
ClinicalTrials.gov study NCT03312738. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
ClinicalTrials.gov study NCT02422615. IPD Sharing: YES. Countries: 30. Publications: 10.
Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibito
ClinicalTrials.gov study NCT01610284. IPD Sharing: YES. Countries: 29. Publications: 2.
OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure
ClinicalTrials.gov study NCT02654587. IPD Sharing: NO. Countries: 10. Publications: 1.
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
ClinicalTrials.gov study NCT03085914. IPD Sharing: YES. Countries: 1. Publications: 1.
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00073528. IPD Sharing: YES. Countries: 29. Publications: 6.
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma
ClinicalTrials.gov study NCT03339219. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.